AI and the War on Time: Accelerating Cancer Research and Longevity Science (eBook, ePUB)
PAYBACK Punkte
0 °P sammeln!
Aging and cancer, two of the most complex challenges in biology, shape the very limits of human health and longevity. The book "AI and the War on Time: Accelerating Cancer Research and Longevity Science" explores how cutting-edge science, artificial intelligence, and regenerative medicine are revolutionizing our understanding of these processes. Scientists have long sought to understand why cells age, how mutations accumulate, and why some changes lead to cancer while others drive the slow decline of aging. Today, AI is accelerating this research, uncovering hidden patterns in vast datasets, p...
Aging and cancer, two of the most complex challenges in biology, shape the very limits of human health and longevity. The book "AI and the War on Time: Accelerating Cancer Research and Longevity Science" explores how cutting-edge science, artificial intelligence, and regenerative medicine are revolutionizing our understanding of these processes. Scientists have long sought to understand why cells age, how mutations accumulate, and why some changes lead to cancer while others drive the slow decline of aging. Today, AI is accelerating this research, uncovering hidden patterns in vast datasets, predicting disease progression, and even identifying potential treatments before they reach clinical trials. From modeling tumor growth to discovering compounds that could slow cellular aging, AI is transforming the future of medicine.
This book is part of science outreach, aimed at raising awareness about the latest advancements in longevity research, cancer biology, and regenerative medicine, making complex scientific ideas accessible to a broader audience. This book delves into the breakthroughs shaping modern healthcare, from stem cell therapy and cellular reprogramming to AI-driven drug discovery and precision medicine. It explores how researchers are redefining aging; not as an inescapable fate, but as a biological process that can be managed, delayed, or even reversed. At the same time, it examines the paradoxical relationship between aging and cancer: while cellular senescence protects against uncontrolled growth, it also contributes to degeneration and disease.
"AI and the War on Time: Accelerating Cancer Research and Longevity Science" reveals how the fusion of AI, biotechnology, and regenerative medicine is opening doors to new possibilities. Will we extend human lifespan without compromising quality of life? Can AI help us outsmart cancer and slow aging? The answers may lie in the convergence of biology and technology. This is not a tale of immortality, but of extending health, vitality, and resilience. The future of medicine is unfolding, and the discoveries of today may reshape the way we think about life itself.
Basudha Banerjee, the author of "AI and the War on Time: Accelerating Cancer Research and Longevity Science", is a dedicated researcher specializing in cancer biology, stem cell research, and regenerative medicine. Currently a Project Associate-I at CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), New Delhi, she has worked extensively on biomaterial-enriched scaffolds for tissue regeneration and chemoresistance in cancer. Her contributions include research collaborations with Ioncure Tech Pvt. Ltd. and co-authoring chapters in Computational Biology for Stem Cell Research (2024). Actively engaged in the scientific community, she has presented her work at international conferences and held leadership roles in academic forums. Passionate about advancing regenerative medicine, Basudha remains committed to exploring innovative solutions in regenerative medicine and biomedical research.
This book is part of science outreach, aimed at raising awareness about the latest advancements in longevity research, cancer biology, and regenerative medicine, making complex scientific ideas accessible to a broader audience. This book delves into the breakthroughs shaping modern healthcare, from stem cell therapy and cellular reprogramming to AI-driven drug discovery and precision medicine. It explores how researchers are redefining aging; not as an inescapable fate, but as a biological process that can be managed, delayed, or even reversed. At the same time, it examines the paradoxical relationship between aging and cancer: while cellular senescence protects against uncontrolled growth, it also contributes to degeneration and disease.
"AI and the War on Time: Accelerating Cancer Research and Longevity Science" reveals how the fusion of AI, biotechnology, and regenerative medicine is opening doors to new possibilities. Will we extend human lifespan without compromising quality of life? Can AI help us outsmart cancer and slow aging? The answers may lie in the convergence of biology and technology. This is not a tale of immortality, but of extending health, vitality, and resilience. The future of medicine is unfolding, and the discoveries of today may reshape the way we think about life itself.
Basudha Banerjee, the author of "AI and the War on Time: Accelerating Cancer Research and Longevity Science", is a dedicated researcher specializing in cancer biology, stem cell research, and regenerative medicine. Currently a Project Associate-I at CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), New Delhi, she has worked extensively on biomaterial-enriched scaffolds for tissue regeneration and chemoresistance in cancer. Her contributions include research collaborations with Ioncure Tech Pvt. Ltd. and co-authoring chapters in Computational Biology for Stem Cell Research (2024). Actively engaged in the scientific community, she has presented her work at international conferences and held leadership roles in academic forums. Passionate about advancing regenerative medicine, Basudha remains committed to exploring innovative solutions in regenerative medicine and biomedical research.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, CY, CZ, D, DK, EW, E, FIN, F, GR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Andere Kunden interessierten sich für
